Debt to EBITDA ratio Analysis of Marksans Pharma - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsDebt to EBITDA of MARKSANS
Mar-250.115Excellent Debt to EBITDA | Mar-240.106Excellent Debt to EBITDA | Growth8.39% |
Debt to EBITDA Analysis of Marksans Pharma
| Debt to EBITDA Ratio 0.115 of Marksans Pharma shows that the company is financially strong and has enough profit to pay off its debt. |
| Debt to EBITDA Ratio of MARKSANS has grown by 8.39 % Compared to previous Financial Year. |
| Debt to EBITDA Ratio with value of 0.143 was highest in Year Mar-23 in last Five Years. |
| Debt to EBITDA Ratio with value of 0.086 was lowest in Year Mar-21 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of 0.115 is lower than Average Debt to EBITDA of 0.118 in last five years. |
Other Debt to EBITDA Related Info of MARKSANS that may interest you.
Marksans Pharma Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| MARKSANS | 180.18 | 178.92 | 0.704 % | Health Services |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Excellent Stability | Screener |
FY - Historical Debt to EBITDA of Marksans Pharma
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | 0.115 | 0.106 | 0.143 | 0.137 | 0.086 | 0.126 | 0.828 |
| Change | 8.39 % | -25.90 % | 4.35 % | 59.68 % | -31.91 % | -84.76 % | -46.18 % |
| Price | 222.47 | 151.90 | 70.40 | 45.50 | 49.95 | 13.90 | 24.95 |
| Price Change | 46.46 % | 115.77 % | 54.73 % | -8.91 % | 259.35 % | -44.29 % | -21.17 % |